Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Johnson & Johnson reports sales for the first quarter of $13 billion
May 18th, 2006
Johnson & Johnson announced sales for the first quarter of $13 billion, an increase of 1.2% as compared to the first quarter of 2005. Operational growth was 3.5% with a negative currency impact of 2.3%. Domestic sales were up 1.6%, while international sales increased .8%, reflecting operational growth of 6.1% and a negative currency impact of 5.3%. Net earnings and diluted earnings per share for the first quarter of 2006 were $3.3 billion and $1.10. The first quarter included an after-tax gain of $368 million associated with the termination of the Guidant acquisition agreement. The first quarter also included after-tax in-process research and...
Source: Biotech Business Week (2006-05-18)
|
